X
[{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"MRM Health","pharmaFlowCategory":"D","amount":"$15.1 million","upfrontCash":"Undisclosed","newsHeadline":"DuPont Nutrition & Biosciences Enters into Collaboration","therapeuticArea":"Endocrinology","highestDevelopmentStatus":"Undisclosed","country":"U.S.A","productType":"Large molecule","productStatus":"Undisclosed","date":"February 2020","url1":"","url2":"","graph1":"Endocrinology","graph2":"Undisclosed"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"DuPont Nutrition & Biosciences Announces Research Collaboration with Rutgers University","therapeuticArea":"Immunology","highestDevelopmentStatus":"Discovery","country":"U.S.A","productType":"Large molecule","productStatus":"Undisclosed","date":"July 2020","url1":"","url2":"","graph1":"Immunology","graph2":"Discovery"}]
Find Clinical Drug Pipeline Developments & Deals by International Flavors and Fragrances
Filters
Companies By Therapeutic Area
Details:
The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation of the microbiome.
Lead Product(s):
Gut-Microbiome
Therapeutic Area: Immunology
Product Name: Undisclosed
Highest Development Status: Discovery
Product Type: Large molecule
Recipient:
Rutgers University
Deal Size: Undisclosed
Upfront Cash: Undisclosed
Deal Type: Collaboration
July 23, 2020
Details:
In collaboration, proprietary MRM Health technology platform and some selected DuPont strains will be combined to develop novel therapeutics based on live bacterial strain combinations.
Lead Product(s):
Gut microbiome based therapeutics
Therapeutic Area: Endocrinology
Product Name: Undisclosed
Highest Development Status: Undisclosed
Product Type: Large molecule
Recipient:
MRM Health
Deal Size: $15.1 million
Upfront Cash: Undisclosed
Deal Type: Collaboration
February 19, 2020